Paroxysmal supraventricular tachycardia in the general population

Marshfield Clinic and the Marshfield Medical Research Foundation, Wisconsin 54449, USA.

OBJECTIVES: We sought to determine the epidemiology and clinical significance of paroxysmal supraventricular tachycardia (PSVT) in the general population. BACKGROUND: Current knowledge of PSVT has been derived primarily from otherwise healthy patients referred to specialized centers. METHODS: We used the resources of the Marshfield Epidemiologic Study Area, a region covering practically all medical care received by its 50,000 residents. A review of 1,763 records identified prevalent cases as of July 1, 1991 and all new cases of PSVT diagnosed from that day until June 30, 1993. A mean follow-up period of 2 years was completed in all incident patients. Patients without other cardiovascular disease were labeled as having "lone PSVT." RESULTS: The prevalence was 2.25/1,000 persons and the incidence was 35/100,000 person-years (95% confidence interval, 23 to 47/100,000). Other cardiovascular disease was present in 90% of males and 48% of females (p = 0.0495). Compared with patients with other cardiovascular disease, those with lone PSVT were younger (mean 37 vs. 69 years, p = 0.0002), had a faster PSVT heart rate (mean 186 vs. 155 beats/min, p = 0.0006) and were more likely to have their condition first documented in the emergency room (69% vs. 30%, p = 0.0377). The onset of symptoms occurred during the childbearing years in 58% of females with lone PSVT versus 9% of females with other cardiovascular disease (p = 0.0272). CONCLUSIONS: There are approximately 89,000 new cases/year and 570,000 persons with PSVT in the United States. In the general population, there are two distinct subsets of patients with PSVT: those with other cardiovascular disease and those with lone PSVT. Our data suggest etiologic heterogeneity in the pathogenesis of PSVT and the need for more population-based research on this common condition.

This article has been cited by other articles:

				Writing Group Members, V. L. Roger, A. S. Go, D. M. Lloyd-Jones, E. J. Benjamin, J. D. Berry, W. B. Borden, D. M. Bravata, S. Dai, E. S. Ford, et al. Heart Disease and Stroke Statistics--2012 Update: A Report From the American Heart Association Circulation, January 3, 2012; 125(1): e2 - e220. [Full Text] [PDF]

				J.-q. Hu, J. Ma, Q. Yang, Z.-l. Liao, Y. Hou, and S. Zhang The characteristics of verapamil-sensitive idiopathic left ventricular tachycardia combined with a left accessory pathway and the effect of radiofrequency catheter ablation Europace, October 19, 2011; (2011) eur330v1. [Abstract] [Full Text] [PDF]

				R. K. Mareedu, I. B. Abdalrahman, K. C. Dharmashankar, J. F. Granada, P.-H. Chyou, P. P. Sharma, P. N. Smith, J. J. Hayes, R. T. Greenlee, and H. Vidaillet Atrial Flutter Versus Atrial Fibrillation in a General Population: Differences in Comorbidities Associated With Their Respective Onset Clin. Med. Res., March 1, 2010; 8(1): 1 - 6. [Abstract] [Full Text] [PDF]

				N W F Linton and S W Dubrey Narrow complex (supraventricular) tachycardias Postgrad. Med. J., October 1, 2009; 85(1008): 546 - 551. [Abstract] [Full Text] [PDF]

				B. Brembilla-Perrot, L. Groben, F. Chometon, J. P. Lethor, P. Admant, J. L. Cloez, I. Popescu, C. Marchal, J. Cedano, A. Abdelaal, et al. Rapid and low-cost method to prove the nature of no documented tachycardia in children and teenagers without pre-excitation syndrome Europace, August 1, 2009; 11(8): 1083 - 1089. [Abstract] [Full Text] [PDF]

				J.#x.;n. Farre, H. J.J. Wellens, J.#x. M. Rubio, and J. Benezet CHAPTER 28 Supraventricular Tachycardias ESC Textbook of Cardiovascular Medicine, January 1, 2009; 2(1): med-9780199566990-chapter - med-9780199566990-chapter. [Abstract] [Full Text] [PDF]

				C. M. Tracy, M. Akhtar, J. P. DiMarco, D. L. Packer, H. H. Weitz, M. A. Creager, D. R. Holmes Jr, G. Merli, G. P. Rodgers, C. M. Tracy, et al. American College of Cardiology/American Heart Association 2006 Update of the Clinical Competence Statement on Invasive Electrophysiology Studies, Catheter Ablation, and Cardioversion: A Report of the American College of Cardiology/American Heart Association/American College of Physicians Task Force on Clinical Competence and Training Developed in Collaboration With the Heart Rhythm Society J. Am. Coll. Cardiol., October 3, 2006; 48(7): 1503 - 1517. [Full Text] [PDF]

				K. A. Ellenbogen, G. O'Neill, E. N. Prystowsky, J. A. Camm, L. Meng, H. D. Lieu, M. Jerling, R. Shreeniwas, L. Belardinelli, A. A. Wolff, et al. Trial to Evaluate the Management of Paroxysmal Supraventricular Tachycardia During an Electrophysiology Study With Tecadenoson Circulation, June 21, 2005; 111(24): 3202 - 3208. [Abstract] [Full Text] [PDF]

				A.-M. Still, P. Raatikainen, A. Ylitalo, H. Kauma, M. Ikäheimo, Y. A. Kesäniemi, and H. V. Huikuri Prevalence, characteristics and natural course of inappropriate sinus tachycardia Europace, January 1, 2005; 7(2): 104 - 112. [Abstract] [Full Text] [PDF]

				G. Steinbeck and C. Reithmann Paroxysmal supraventricular tachycardia: preferential use of either adenosine or verapamil is dependent on the rate of tachycardia? Eur. Heart J., August 1, 2004; 25(15): 1277 - 1278. [Full Text] [PDF]

				P. Ballo, D. Bernabo, and S. A. Faraguti Heart rate is a predictor of success in the treatment of adults with symptomatic paroxysmal supraventricular tachycardia Eur. Heart J., August 1, 2004; 25(15): 1310 - 1317. [Abstract] [Full Text] [PDF]

				Committee Members, C. Blomstrom-Lundqvist, M. M. Scheinman, E. M. Aliot, J. S. Alpert, H. Calkins, A. J. Camm, W. B. Campbell, D. E. Haines, K. H. Kuck, et al. ACC/AHA/ESC guidelines for the management of patients with supraventricular arrhythmias --executive summary: a report of the American college of cardiology/American heart association task force on practice guidelines and the European society of cardiology committee for practice guidelines (writing committee to develop guidelines for the management of patients with supraventricular arrhythmias) Developed in Collaboration with NASPE-Heart Rhythm Society J. Am. Coll. Cardiol., October 15, 2003; 42(8): 1493 - 1531. [Full Text] [PDF]

				C. Blomstrom-Lundqvist, M. M. Scheinman, E. M. Aliot, J. S. Alpert, H. Calkins, A. J. Camm, W. B. Campbell, D. E. Haines, K. H. Kuck, B. B. Lerman, et al. ACC/AHA/ESC Guidelines for the Management of Patients With Supraventricular Arrhythmias*--Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Supraventricular Arrhythmias) Circulation, October 14, 2003; 108(15): 1871 - 1909. [Full Text] [PDF]

				Committee Members, C. Blomstrom-Lundqvist, M. M Scheinman, E. M Aliot, J. S Alpert, H. Calkins, A.J. Camm, W.B. Campbell, D. E Haines, K. H Kuck, et al. ACC/AHA/ESC guidelines for the management of patients with supraventricular arrhythmias--executive summary: A Report of the American College of Cardiology/American HeartAssociation Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines(Writing Committee to Develop Guidelines for the Management of Patients With Supraventricular Arrhythmias)Developed in collaboration with NASPE-Heart Rhythm Society Eur. Heart J., October 2, 2003; 24(20): 1857 - 1897. [Full Text] [PDF]

				R. T. Greenlee Measuring Disease Frequency in the Marshfield Epidemiologic Study Area (MESA) Clin. Med. Res., October 1, 2003; 1(4): 273 - 280. [Abstract] [Full Text] [PDF]

				J. D. Ferguson and J. P. DiMarco Contemporary Management of Paroxysmal Supraventricular Tachycardia Circulation, March 4, 2003; 107(8): 1096 - 1099. [Full Text] [PDF]

				R. J Schilling Which patient should be referred to an electrophysiologist: supraventricular tachycardia Heart, March 1, 2002; 87(3): 299 - 304. [Full Text] [PDF]

				C. H.F. Cheng, G. D. Sanders, M. A. Hlatky, P. Heidenreich, K. M. McDonald, B. K. Lee, M. S. Larson, and D. K. Owens Cost-Effectiveness of Radiofrequency Ablation for Supraventricular Tachycardia Ann Intern Med, December 5, 2000; 133(11): 864 - 876. [Abstract] [Full Text] [PDF]

				J. Granada, W. Uribe, P.-H. Chyou, K. Maassen, R. Vierkant, P. N. Smith, J. Hayes, E. Eaker, and H. Vidaillet Incidence and predictors of atrial flutter in the general population J. Am. Coll. Cardiol., December 1, 2000; 36(7): 2242 - 2246. [Abstract] [Full Text] [PDF]

				C. M. Tracy, M. Akhtar, J. P. DiMarco, D. L. Packer, H. H. Weitz, W. L. Winters, J. L. Achord, A. W. Boone, J. W. Hirshfeld Jr, B. H. Lorell, et al. American College of Cardiology/American Heart Association Clinical Competence Statement on invasive electrophysiology studies, catheter ablation, and cardioversion: A report of the american college of cardiology/american heart association/american college of physicians-american society of internal medicine task force on clinical competence J. Am. Coll. Cardiol., November 1, 2000; 36(5): 1725 - 1736. [Full Text] [PDF]

				C. M. Tracy, M. Akhtar, J. P. DiMarco, D. L. Packer, H. H. Weitz, W. L. Winters, J. L. Achord, A. W. Boone, J. W. Hirshfeld Jr, B. H. Lorell, et al. American College of Cardiology/American Heart Association Clinical Competence Statement on Invasive Electrophysiology Studies, Catheter Ablation, and Cardioversion : A Report of the American College of Cardiology/American Heart Association/American College of Physicians-American Society of Internal Medicine Task Force on Clinical Competence Circulation, October 31, 2000; 102(18): 2309 - 2320. [Full Text] [PDF]